Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.
Villanueva C, Aracil C, Colomo A, Lopez-Balaguer JM, Piqueras M, Gonzalez B, Torras X, Guarner C, Balanzo J. Villanueva C, et al. Among authors: aracil c. Aliment Pharmacol Ther. 2009 Feb 15;29(4):397-408. doi: 10.1111/j.1365-2036.2008.03880.x. Epub 2008 Nov 1. Aliment Pharmacol Ther. 2009. PMID: 19006538 Clinical Trial.
Current endoscopic therapy of variceal bleeding.
Villanueva C, Colomo A, Aracil C, Guarner C. Villanueva C, et al. Among authors: aracil c. Best Pract Res Clin Gastroenterol. 2008;22(2):261-78. doi: 10.1016/j.bpg.2007.11.012. Best Pract Res Clin Gastroenterol. 2008. PMID: 18346683 Review.
[Combined treatments for esophageal varices].
Villanueva C, Aracil C, López-Balaguer JM, Balanzó J. Villanueva C, et al. Among authors: aracil c. Gastroenterol Hepatol. 2003 Oct;26(8):514-23. doi: 10.1016/s0210-5705(03)70403-8. Gastroenterol Hepatol. 2003. PMID: 14534024 Review. Spanish. No abstract available.
Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis.
Garcia Garcia de Paredes A, Villanueva C, Blanco C, Genescà J, Manicardi N, Garcia-Pagan JC, Calleja JL, Aracil C, Morillas RM, Poca M, Peñas B, Augustin S, Abraldes JG, Alvarado E, Royo F, Garcia-Bermejo ML, Falcon-Perez JM, Bañares R, Bosch J, Gracia-Sancho J, Albillos A. Garcia Garcia de Paredes A, et al. Among authors: aracil c. JHEP Rep. 2021 Sep 27;3(6):100368. doi: 10.1016/j.jhepr.2021.100368. eCollection 2021 Dec. JHEP Rep. 2021. PMID: 34712934 Free PMC article.
Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.
Hernández-Conde M, Llop E, Carrillo CF, Tormo B, Abad J, Rodriguez L, Perelló C, Gomez ML, Martínez-Porras JL, Puga NF, Trapero-Marugan M, Fraga E, Aracil CF, Panero JLC. Hernández-Conde M, et al. Among authors: aracil cf. World J Gastroenterol. 2020 Nov 14;26(42):6658-6668. doi: 10.3748/wjg.v26.i42.6658. World J Gastroenterol. 2020. PMID: 33268953 Free PMC article.
Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis.
Fortea JI, Alvarado-Tapias E, Simbrunner B, Ezcurra I, Hernández-Gea V, Aracil C, Llop E, Puente A, Roig C, Reiberger T, García-Pagan JC, Calleja JL, Ferrero-Gregori A, Mandorfer M, Villanueva C, Crespo J. Fortea JI, et al. Among authors: aracil c. J Hepatol. 2024 Dec 17:S0168-8278(24)02772-7. doi: 10.1016/j.jhep.2024.12.017. Online ahead of print. J Hepatol. 2024. PMID: 39701300
Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to β-blockers: A double-blind, placebo-controlled, randomized-trial.
Alvarado-Tapias E, Brujats A, Puente A, Ardevol A, Rodriguez-Arias A, Fajardo J, Pavel O, Garcia-Guix M, Aracil C, Poca M, Cuyàs B, Cantó E, Montañés R, Garcia-Osuna A, Escorsell À, Torras X, Villanueva C. Alvarado-Tapias E, et al. Among authors: aracil c. Hepatology. 2024 Nov 7. doi: 10.1097/HEP.0000000000001148. Online ahead of print. Hepatology. 2024. PMID: 39509369
Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial.
Dajti E, Villanueva C, Berzigotti A, Brujats A, Albillos A, Genescà J, García-Pagán JC, Colecchia A, Bosch J; PREDESCI trial investigators; A study by the Baveno Cooperation, an EASL Consortium. Dajti E, et al. J Hepatol. 2024 Sep 19:S0168-8278(24)02553-4. doi: 10.1016/j.jhep.2024.09.014. Online ahead of print. J Hepatol. 2024. PMID: 39303875 Free article.
56 results